Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

Exclusion Criteria

• •1\. Pregnant and/or breastfeeding woman
• •2\. Hypersensitivity to seawater and/or known allergies to any of the ingredients of the spray.
• •3\. Diseases causing narrowing of the airways (e.g. asthma, chronic obstructive pulmonary disease (COPD)) and/or respiratory insufficiency.
• •4\. Patients with uncontrolled asthma (GINA score greater than or equal to 4)
• •5\. Patients undergoing allergy desensitization
• •6\. Patients suffering from chronic nasal obstruction due to a deformation of the nasal wall or nasal polyps. creams or gels.
• •7\. Patients taking local and systemic vasoconstrictors, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, and local antiseptics.
• •8\. Concomitant use of other nasal sprays, essential oils for local nasal use, creams, or gels for the nose.
• •9\. Patients under guardianship, conservatorship, or legal protection.